Physician profile
Robert Ong
NPI 1396729760
$7,795.89
in general payments reported to CMS, 2019-2025
19 companies · $230 in 2025
The $230 reported for 2025 was more than what 83% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,601 · 2020: $468 · 2021: $1,130 · 2022: $1,242 · 2023: $777 · 2024: $1,349 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,608 · Travel and Lodging: $711 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.61 |
| Travel and Lodging | $710.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,275.04 | 2019-2024 | Senza |
| Medtronic USA, INC. | $947.98 | 2019-2020 | |
| Medtronic, INC. | $614.70 | 2021-2023 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Enduromed, LLC | $550.00 | 2024 | |
| Abbott Laboratories | $537.66 | 2022-2023 | Proclaim |
| Pfizer INC. | $514.08 | 2023-2024 | |
| Aimmune Therapeutics, INC. | $327.11 | 2024-2025 | Zenpep |
| Nalu Medical, INC. | $323.49 | 2021 | |
| Arthrex, INC. | $304.86 | 2024 | Arthrex |
| Biohaven Pharmaceutical Holding Company Ltd. | $275.57 | 2022 | |
| Spr Therapeutics, INC | $268.11 | 2022 | |
| Stryker Corporation | $186.18 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $169.99 | 2021 | |
| Abbvie INC. | $136.35 | 2022 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $90.00 | 2022 | |
| Amgen INC. | $88.81 | 2019 | |
| Becton, Dickinson and Company | $37.00 | 2024 | |
| Bioventus LLC | $23.96 | 2023 | Stimrouter Implantable Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.